1. Hanna EY, Lee S, Fan CY, Suen JY. In: Cummings CW, Flint PW, editors. Benign neoplasms of the salivery glands. Cummings Otolaryngology: Head & Neck Surgery. 2005. 4th ed. Philadelphia: Mosby; p. 1348-1377.
2. Suh MW, Hah JH, Lee KB, Kwon SK, Jung YH, Sung MW, et al. Immunohistochemical characteristics of primary and recurrent pleomorphic adenoma. Korean J Head Neck Oncol. 2005 11;21(2):146-150.
3. Junquera L, Alonso D, Sampedro A, Fresno F, Albertos JM, Lopez-Arranz JS. Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck. 1999 10;21(7):652-656. PMID:
10487953.
4. Bankamp DG, Bierhoff E. Proliferative activity in recurrent and non-recurrent pleomorphic adenoma of the salivary glands. Laryngorhinootologie. 1999 2;78(2):77-80. PMID:
10226990.
5. Leverstein H, Tiwari RM, Snow GB, van der Wal JE, van der Waal I. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland: analysis and results in 40 patients. Eur Arch Otorhinolaryngol. 1997;254(7):313-317. PMID:
9298665.
6. Jackson SR, Roland NJ, Clarke RW, Jones AS. Recurrent pleomorphic adenoma. J Laryngol Otol. 1993 6;107(6):546-549. PMID:
8393908.
7. Hancock BD. Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases. Ann R Coll Surg Engl. 1999 9;81(5):299-301. PMID:
10645170.
8. Bradley PJ. Recurrent salivary gland pleomorphic adenoma: etiology, management, and results. Curr Opin Otolaryngol Head Neck Surg. 2001 4;9(2):100-108.
9. Seifert G, Langrock I, Donath K. A pathological classification of pleomorphic adenoma of the salivary glands (author's transl). HNO. 1976 12;24(12):415-426. PMID:
1002574.
10. Frazell EL. Clinical aspects of tumors of the major salivary glands. Cancer. 1954 7;7(4):637-659. PMID:
13172680.
11. Ghosh S, Panarese A, Bull PD, Lee JA. Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management: a 12.5-year mean follow-up study of histologically marginal excisions. Clin Otolaryngol Allied Sci. 2003 6;28(3):262-266. PMID:
12755769.
12. Buchman C, Stringer SP, Mendenhall WM, Parsons JT, Jordan JR, Cassisi NJ. Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence. Laryngoscope. 1994 10;104(10):1231-1234. PMID:
7934593.
13. Henriksson G, Westrin KM, Carlsoo B, Silfversward C. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer. 1998 2 15; 82(4):617-620. PMID:
9477091.
14. Natvig K, Soberg R. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study. Head Neck. 1994;May–Jun;16(3):213-217. PMID:
8026950.
15. Carew JF, Spiro RH, Singh B, Shah JP. Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol Head Neck Surg. 1999 11;121(5):539-542. PMID:
10547466.
16. Glas AS, Vermey A, Hollema H, Robinson PH, Roodenburg JL, Nap RE, et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients. Head Neck. 2001 4;23(4):311-316. PMID:
11400233.
17. Hoorweg JJ, Hilgers FJ, Keus RB, Zoetmulder FA, Loftus BM. Metastasizing pleomorphic adenoma: a report of three cases. Eur J Surg Oncol. 1998 10;24(5):452-455. PMID:
9800983.
18. Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Clinically aggressive metastasizing pleomorphic adenoma: report of two cases. Head Neck. 1997 10;19(7):629-633. PMID:
9323153.
19. Sunardhi-Widyaputra S, Van Damme B. Immunohistochemical pattern of Bcl-2- and PTHrP-positive cells in primary, in recurrent and in carcinoma in pleomorphic adenomas. Pathol Res Pract. 1995 12;191(12):1186-1191. PMID:
8927564.
20. McGregor AD, Burgoyne M, Tan KC. Recurrent pleomorphic salivary adenoma: the relevance of age at first presentation. Br J Plast Surg. 1988 3;41(2):177-181. PMID:
2832025.
21. Fee WE Jr, Goffinet DR, Calcaterra TC. Recurrent mixed tumors of the parotid gland results of surgical therapy. Laryngoscope. 1978 2;88(2 Pt 1):265-273. PMID:
202823.
22. Laskawi R, Schott T, Schroder M. Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg. 1998 2;36(1):48-51. PMID:
9578257.
23. Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol. 1995 2;104(2):100-104. PMID:
7857010.
24. Glas AS, Hollema H, Nap RE, Plukker JT. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland. Cancer. 2002 4;94(8):2211-2216. PMID:
12001119.
25. Naeim F, Forsberg MI, Waisman J, Coulson WF. Mixed tumors of the salivary glands: growth pattern and recurrence. Arch Pathol Lab Med. 1976 5;100(5):271-275. PMID:
178290.